Trial Profile
A real world, retrospective study to investigate evidence on cardiovascular outcomes and healthcare costs and resource utilisation in high risk patients with hyperlipidemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2017
Price :
$35
*
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 24 May 2017 New trial record